Download - PELAYANAN TERPADU RETINOBLASTOMA
![Page 1: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/1.jpg)
PELAYANAN TERPADU RETINOBLASTOMAMONITORING EFEK SAMPING KEMOTERAPI
PMN RS MATA CICENDO BANDUNG
![Page 2: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/2.jpg)
LATAR BELAKANG
• Pelayanan terpadu Retinoblastoma (RB) merupakan layanan baru
RSMC
• Layanan Unggulan 2015−2019
• Setiap tenaga medis terpapar montoring efek samping kemoterapi
• Efek samping setiap anak berbeda dengan pemberian obat
kemoterapi yang sama
![Page 3: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/3.jpg)
ALUR PASIEN
• Emergensi atau non emergensi
• Tentukan apakah pasien layak diberikan kemoterapi atau tidak
• Penyakit penyerta yang lain
• Penggunaan HCR/HCU
•MULTIDISIPLIN
![Page 4: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/4.jpg)
Approach to a Child with Leucocoria.Vijay Kumarmes. DOS Times - Vol. 19, No. 8 February, 2014
![Page 5: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/5.jpg)
International Intraocular Retinoblastoma Classification
Murphree AL. Intraocular Retinoblastoma: the Case for a New Group Classification. Ophthalmol Clin N Am. 2005
Kemoterapi±fokal
Kemoterapi±fokal
Enukleasi+ ±fokal
kemoterapi
Kemoterapi±fokal
Fokal+kemoterapi
![Page 6: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/6.jpg)
TENTUKAN LETAK TUMOR DAN UKUR DIAMETER TERBESAR
Even though this is the smallestcircle, its diameter representsthe largest chord length in thedrawing. This region containsthe optic disc, where the opticnerve passes through the sclera,as well as the macula (whichsurrounds the fovea) which isthe region of greatest opticalacuity found at the posteriorpole of the eye.
FIG. 1. The anatomy of the right eye in a transverse cut relates
to the fundus view diagram. Two tumors labeled A and B
located on a transverse great circle are shown in both views.
The next largest circle represents the circumference in the coronal plane at the ora serrata, which is thepoint at which the retina terminates at the cilliary body. The region contained between this circle and theequator represents a band on the inside surface of the eye from the equator to the ora serrata. Theoutermost circle in the fundus diagram is the circumference in the coronal plane at the limbus, which isthe point at which the sclera terminates at the cornea. This circle, although apparently the largest on thediagram, actually represents the smallest diameter of the three.
As the central point of the diagram represents the posterior pole of the eye, any radial displacement fromthis point represents a shift in the anterior direction along a retinal meridian, so that the most anteriorposition of the diagram is reached at the outermost circle. The clock position of the tumor also givesgeographic information with respect to the coronal plane of the patient, so that 12 o'clock is superior, 6o'clock is inferior, 3 o'clock is to the patient's left, and 9 o'clock is to the patient's right. The location of theoptic nerve is indicated by a small solid circle along the 3 to 9 o'clock line (90* meridian). As the opticnerve lies medially to the macula, the position of this solid circle identifies the right or left eye. In theupper half of Fig. 1 the eye is shown containing two tumors labeled A and B and their correspondingpositions in the fundus diagram are also shown. As tumor A lies in the posterior hemisphere on the rightside, it is contained entirely in the smallest concentric circle of the fundus diagram. Tumor B lies on the
left of the optic axis between the equator and the ora seratta, thus it is located between the smallest and
MAKULA
EKUATOR
ORA
![Page 7: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/7.jpg)
Ekuator
![Page 8: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/8.jpg)
ORBITAL RB
![Page 9: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/9.jpg)
B Scan
Approach to a Child with Leucocoria.Vijay Kumarmes. DOS Times - Vol. 19, No. 8 February, 2014
Kalsifikasi
High Internal reflectivity and spikes
![Page 10: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/10.jpg)
CT scan dan MRI
Approach to a Child with Leucocoria.Vijay Kumarmes. DOS Times - Vol. 19, No. 8 February, 2014
Keterlibatannervus opticus
Kalsifikasi
![Page 11: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/11.jpg)
DPJP Tergantung Dari Tindakan
• Enukleasi→ ROO
• Kemoterapi→ IK Anak
• TTT → Vitreoretina
• EUA → PO
• Enukleasi, TTT, EUA → Tindakan yang paling tinggi pembiayaan (ROO)
![Page 12: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/12.jpg)
PPK DAN CP (PO, ROO, RETINA, IK ANAK)
![Page 13: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/13.jpg)
![Page 14: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/14.jpg)
![Page 15: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/15.jpg)
![Page 16: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/16.jpg)
![Page 17: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/17.jpg)
![Page 18: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/18.jpg)
FARMASI
Kelengkapan obatsitostatika
![Page 19: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/19.jpg)
RUANGAN KEMOTERAPI
![Page 20: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/20.jpg)
RUANGAN KEMOTERAPI
![Page 21: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/21.jpg)
SKENARIO PASIEN
• Pasien gelombang 1 sebanyak 2 orang skrining persiapan kemoterapi hariSenin
• Permintaan obat ke Farmasi• Senin sore pasien masuk ke ruangan• Selasa pagi diberikan kemoterapi hari I • Rabu pagi diberikan kemoterapi hari II• Rabu siang pasien pulang• Penjadwalan kemoterapi berikutnya 3 minggu yang akan datang
• Pasien masuk kembali (gelombang 2 sebanyak 2 orang)Rabu siang/sore untuk mulai kemoterapi Kamis
TOTAL: 2 gelombang @2 orang= 4 pasien/minggu
![Page 22: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/22.jpg)
Mengapa Diperlukan PengetahuanEfek Samping Kemoterapi?
To Err is Human
![Page 23: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/23.jpg)
EFEK SAMPINGKEMOTERAPI• Mual dan muntah
• Diare
• Konstipasi
• Nyeri → skala nyeri
• Mukositis
• Kehilangan berat badan
• Body image changes
• Rontok/ alopecia
• Perubahan warna kulit
![Page 24: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/24.jpg)
VINCRISTINE
• Neurotoksisitas (neuropati perifer, disfungsi sistem sarafotonom, parese saraf kranialis, ataksia, buta kortikal, nyeri tulang, punggung, ekstremitas, rahang, kelenjar parotid)
• Konstipasi, nyeri perut, ileus paralitik (mual, muntah, diare lebih jarang)
• Alopecia, ruam kulit, demam
• Ekstravasasi menimbulkan nekrosis jaringan lokal
• Mielosupresi
• Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
• Reaksi hipersensitivitas
• Azoospermia dan amenorea
![Page 25: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/25.jpg)
CATATAN KHUSUS VINCRISTINE
• Pengurangan dosis pada anak dengan disfungsi hepar
• Bolus/drip
• Ekstravasasi→ infus hentikan, kompres es ke arah ekstravasasi, elevasi ekstremitas yang terkena
• Hati-hati kontaminasi pada mata
• Diet tinggi serat→ Gizi
• Lakukan pemeriksaan neurologis sebelum dimulainya kemoterapi
![Page 26: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/26.jpg)
ETOPOSIDE
• Mielosupresi (leukopenia dapat terjadi 10−14 hari setelahterapi dengan pemulihan hari ke 21)
• Mual dan muntah
• Anoreksia
• Alopesia
• Mukositis dan diare
• Reaksi hipersensitivitas (menggigil, demam, bronkospasme, takikardia, bengkak wajah, hipotensi→ 2%)
• Sensasi pengecapan seperti rasa logam
• Reaksi inflamasi lokal pada tempat suntikan
![Page 27: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/27.jpg)
CATATAN KHUSUS ETOPOSIDE
• Hati-hati pada pasien disfungsi ginjal dan disfungsi hepar(penyesuaian dosis)
• Kecepatan dikurangi bila terjadi hipotensi
• Reaksi anafilaksis
• Pantau tanda flebitis
![Page 28: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/28.jpg)
CARBOPLATIN
• Mielosupresi (trombositopenia dengan titik nadir tercapai pada harike 21)
• Mual dan muntah
• Nefrotoksik (lebih toksik cisplatin)
• Neuropati perifer (<10% pasien terutama dengan keluhan yang samasebelumnya)
• Peningkatan enzim hepar
• Reaksi alergi
• Jarang alopesia
![Page 29: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/29.jpg)
CATATAN KHUSUS CARBOPLATIN
• Hati-hati pada gangguan fungsi ginjal
• Tidak bersifat emetogenik namun premedikasi antiemetik sangatdisarankan
• Pre hidrasi dan post hidrasi tidak diperlukan
• Reaksi hipersensitivitas meningkat dari 1% menjadi 27% pada pasienyang telah menerima regimen >7 kali regimen berbasis carboplatin
![Page 30: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/30.jpg)
THE CARE OF RETINOBLASTOMA PATIENTS IS NOT THE RESULT OF A SINGLE CLINICIAN, BUT IT IS A CONSORTIUM OF MULTIPLE SUBSPECIALTIES
Aparna Ramasubranian
Carol L. Shields
![Page 31: PELAYANAN TERPADU RETINOBLASTOMA](https://reader031.vdocuments.pub/reader031/viewer/2022012518/61923297cb48fe20240be956/html5/thumbnails/31.jpg)
TERIMA KASIH